PCSK9 Eligibility Calculator
Evaluate clinical eligibility for PCSK9 inhibitor therapy based on LDL levels and cardiovascular history.
Input Parameters
Enter details for calculation.
Eligibility Verdict
Expert Tip
PCSK9 inhibitors are indicated for secondary prevention in patients with ASCVD who have LDL ≥ 70 mg/dL despite maximally tolerated statin therapy.
Calculation Methodology & Details
Formula
Evaluates LDL thresholds in secondary prevention settings.
Important Disclaimer
The calculations provided are for educational and general informational purposes only. They do not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
How Eligibility is Evaluated
Follow these steps to use this calculator:
Enter LDL Level
Input current LDL value.
Log Medical History
Select if prior heart attack/stroke is present.
Related Calculators
View All Health Tools →Detailed Insights & Expert Guide
ℹ️ About this Calculation
This clinical cardiovascular calculator provides precise hemodynamics assessment, ischemic heart disease risk stratification, electrophysiology calculations, and vascular disease evaluation based on ACC/AHA guidelines.
Variable Glossary
Vascular & ECG Data
Systolic/diastolic blood pressure, pulse rate, ECG intervals (QT/RR), or ankle-brachial Doppler pressures.
Hemodynamic Scores
Mean arterial pressure (MAP), corrected QTc interval, ASCVD 10-year risk percentage, or ejection fraction.
How to Calculate Step-by-Step
Step 1
Input hemodynamic vitals, lab values, or ECG measurement parameters.
Step 2
Select patient demographics, clinical comorbidities, or exercise test responses.
Step 3
Review calculated risk scores, hemodynamic parameters, and clinical classification recommendations.